Skip to main content
. 2015 Nov;6(11-12):490–502. doi: 10.18632/genesandcancer.89

Figure 3. Viability and retinoid-related survival of CRBP-1-transfected A549 adenocarcinoma cells.

Figure 3

A, Serum-dependent of CRBP-1+ A549 cells growth is increased compared to CRBP-1 cells. B-C, MTT assay shows reduced viability of CRBP-1+ compared to CRBP-1 A549 cells after 1 and 2 days of atRA and ROL treatment in the presence of 0.1% FBS. Values are expressed as means ± SEM of three different experiments; *p < 0.05, **p < 0.005, ***p <<0.0005.